欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/4257/003
药品名称Oxycodon comp - HEXAL 20 mg/10 mg Retardtabletten
活性成分
    • NALOXONE HYDROCHLORIDE hydrochloride 10.0 mg
    • oxycodone hydrochloride 20.0 mg
剂型Prolonged-release tablet
上市许可持有人Hexal Aktiengesellschaft Industriestr. 25 83607 Holzkirchen Germany
参考成员国 - 产品名称Germany (DE)
Oxycodon-HCl/Naloxon-HCl HEXAL 20 mg/10 mg Retardtabletten
互认成员国 - 产品名称
    • Ireland (IE)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Czechia (CZ)
      Oxycodon/Naloxon Sandoz 20 mg/10 mg
    • Slovakia (SK)
      Oxycodone/Naloxone Sandoz 20 mg/10 mg
    • Slovenia (SI)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Portugal (PT)
    • Norway (NO)
许可日期2015/12/07
最近更新日期2024/04/29
药物ATC编码
    • N02AA55 oxycodone and naloxone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase